Skip to content

Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee Osteoarthritis

The Impact of Patient-Provider Interaction on Response to Acupuncture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00059345
Enrollment
639
Registered
2003-04-24
Start date
2002-09-30
Completion date
2006-08-31
Last updated
2013-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Acupuncture, Arthritis

Brief summary

Interactions between patients and healthcare providers may have a significant impact on a patient's response to therapy. In this study, patients with osteoarthritis (OA) of the knee will receive either acupuncture or sham acupuncture. The acupuncturists will be trained to interact with the patients in specific ways. The study will evaluate those interactions.

Detailed description

This study will examine placebo responses in the context of practitioner-patient interactions at the time of the encounter. Phase 1 of this study identified patient-related determinants of placebo response, such as beliefs and expectations toward treatment of knee OA with acupuncture. Phase 2 of the study evaluated an assessment tool to measure these determinants. Phase 3 of the study is a randomized controlled trial to evaluate whether placebo effects in patients with knee OA can be enhanced by the acupuncturists' communicative style, which can affect a patient's cognitive expectancies and beliefs. Patients will initially be randomized to one of two groups, each with a different model for practitioner-patient interaction. Acupuncture practitioners will be trained to follow semi-structured communicative styles, including traditional approaches in Chinese medicine and techniques previously described in patient-doctor communications studies. Within each of these groups, patients will be further randomized to receive either acupuncture or sham acupuncture. Patients will have 6 weeks of biweekly treatment visits. Patients will be followed for 6 months. Visits will be weekly during the first 6 weeks of the study and monthly thereafter. The study will also include a natural cohort group composed of patients on a study waiting list; these patients will be offered acupuncture 3 months after study entry.

Interventions

PROCEDUREAcupuncture

Electroacupuncture treatments provided two times per week for 6 weeks

PROCEDUREPlacebo acupuncture

Placebo acupuncture treatments provided 2 times per week for 6 weeks

OTHERUsual Care

Usual care for knee osteoarthritis

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* OA diagnosis according to the American College of Rheumatology criteria * Pain in the knee of at least 3 or more on a 0 to 10 scale (0 none, 10 extreme pain) within 2 weeks prior to study entry * Stable treatment with anti-inflammatory and analgesic medications during the month prior to study entry * If receiving glucosamine, stable dosage for 2 months prior to study entry * Adequate cognitive status as determined by the study officials * Living in the community * Ability to communicate in English without a translator * Access to a telephone

Exclusion criteria

* Other diagnosed joint diseases, such as rheumatoid arthritis * Previous treatment with acupuncture (for any condition) * Intra-articular injections in the knee in the 2 months prior to study entry

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale3-month
Joint-Specific Multidimensional Assessment of Pain (J-MAP) to evaluate placebo effects on the different dimensions of pain3-month
Patient satisfaction with their knee condition (SKIP)3-month

Secondary

MeasureTime frame
Locus of controlBaseline
Optimism3-month
Self-efficacybaseline
Cognitive pain3-month
SF-123-month
Social support3-month
Patient reaction3-month
Physician trust3-month
Anxiety3-month
Range of motion of each knee3-month
Timed walking test3-month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026